MMBG Investment Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Hold
1,248
0.02% 166
2026
Q1
$229K Hold
1,248
0.02% 167
2025
Q4
$220K Buy
+1,248
New +$204K 0.02% 173
2024
Q4
Sell
-1,800
Closed -$349K 159
2024
Q3
$349K Sell
1,800
-650
-27% -$136K 0.04% 142
2024
Q2
$568K Hold
2,450
0.06% 109
2024
Q1
$528K Hold
2,450
0.06% 118
2023
Q4
$634K Hold
2,450
0.07% 109
2023
Q3
$630K Hold
2,450
0.08% 102
2023
Q2
$696K Hold
2,450
0.08% 99
2023
Q1
$681K Hold
2,450
0.09% 101
2022
Q4
$678K Hold
2,450
0.09% 101
2022
Q3
$654K Hold
2,450
0.09% 100
2022
Q2
$500K Hold
2,450
0.06% 114
2022
Q1
$516K Hold
2,450
0.05% 121
2021
Q4
$588K Buy
+2,450
New +$630K 0.06% 120

Other funds holding BIIB

MMBG Investment Advisors's BIIB Position: Q2 2026 in Review

MMBG Investment Advisors held its Biogen (BIIB) position steady in Q2 2026 at 1,248 shares worth $270K. The position accounts for 0.02% of the portfolio, ranked #166.

MMBG Investment Advisors first reported a position in BIIB in Q4 2021 and has held it in 15 quarters since. The position peaked at $696K in Q2 2023. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • MMBG Investment Advisors held 1,248 shares of Biogen worth $270K as of Q2 2026.
  • MMBG Investment Advisors left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of MMBG Investment Advisors's portfolio in Q2 2026, its #166 holding.
  • MMBG Investment Advisors first reported a position in Biogen in Q4 2021 and has held it in 15 quarters since.
  • MMBG Investment Advisors's Biogen position peaked at $696K in Q2 2023.
  • 684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on MMBG Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.